Tag Archives: business model

$20 Billion 'Lifestyle' Market Immune to Costly Regulations, says Alphaeon CEO

You can’t defraud the government if you aren’t handling its money, explains Robert Grant, CEO of Alphaeon, a lifestyle healthcare company. Pharma free-market advocates take note. If you no longer had to worry about the Anti-Kickback Statute, Stark Law or the Sunshine Act, would your professional marketing strategy change? Probably, if you like making money. […]
Posted in FDA, Global, Legal, Market Access, People, pricing, R&D, Regulatory, social media, Strategy, Technology | Also tagged , , , , , , , , , , , , , , , , | Leave a comment

Meaningful Uses of HIT?

A diverse group of HIT professionals – including physicians, academics, developers and entrepreneurs – gathered at Sudler & Hennessey’s Health and Technology Summit in New York City to discuss the challenges related to health information technology implementation, and the ways to move forward.
Posted in Strategy | Also tagged , , , , , | Leave a comment

Clayton Christensen on the Future of Pharma

A keynote speaker at the 9thAnnual SaS Health Care & Life Sciences Executive Conference on May 10, ‘disruptive’ author of The Innovator’s Dilemma and Harvard business professor Clayton Christensen sat down with PharmExec to discuss the future of the pharmaceutical industry, and what Mitt Romney could bring to the White House.
Posted in Biotech, Events, FDA, healthcare, IP, leadership, People, R&D, Regulatory, Safety, Technology, Uncategorized | Also tagged , , , , , , , , , , , | 1 Comment
  • Categories

  • Meta